Mesirow Financial Investment Management Inc. Takes Position in Synopsys, Inc. (NASDAQ:SNPS)

Mesirow Financial Investment Management Inc. acquired a new stake in Synopsys, Inc. (NASDAQ:SNPSFree Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 341 shares of the semiconductor company’s stock, valued at approximately $203,000.

Several other hedge funds also recently bought and sold shares of SNPS. Swedbank AB purchased a new stake in shares of Synopsys in the 1st quarter valued at about $1,051,637,000. Price T Rowe Associates Inc. MD raised its stake in Synopsys by 39.6% in the first quarter. Price T Rowe Associates Inc. MD now owns 5,337,602 shares of the semiconductor company’s stock valued at $3,050,441,000 after purchasing an additional 1,514,449 shares in the last quarter. GQG Partners LLC lifted its position in Synopsys by 91.6% during the first quarter. GQG Partners LLC now owns 2,095,100 shares of the semiconductor company’s stock valued at $1,197,350,000 after purchasing an additional 1,001,371 shares during the last quarter. Sustainable Growth Advisers LP purchased a new position in Synopsys in the 2nd quarter worth approximately $572,050,000. Finally, Capital World Investors increased its holdings in shares of Synopsys by 12.5% in the 1st quarter. Capital World Investors now owns 7,369,890 shares of the semiconductor company’s stock worth $4,211,892,000 after buying an additional 818,485 shares during the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Synopsys Stock Down 1.3 %

Shares of SNPS opened at $495.95 on Thursday. The stock has a market capitalization of $75.99 billion, a P/E ratio of 53.91, a PEG ratio of 3.23 and a beta of 1.08. Synopsys, Inc. has a twelve month low of $440.62 and a twelve month high of $629.38. The firm has a fifty day simple moving average of $530.00 and a two-hundred day simple moving average of $557.62.

Synopsys (NASDAQ:SNPSGet Free Report) last posted its earnings results on Wednesday, August 21st. The semiconductor company reported $3.43 earnings per share for the quarter, topping analysts’ consensus estimates of $3.28 by $0.15. Synopsys had a net margin of 24.06% and a return on equity of 22.09%. The company had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.52 billion. During the same period in the prior year, the business posted $2.17 earnings per share. Synopsys’s revenue for the quarter was up 12.7% on a year-over-year basis. Sell-side analysts expect that Synopsys, Inc. will post 9.45 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts recently commented on SNPS shares. Needham & Company LLC reissued a “buy” rating and issued a $640.00 target price on shares of Synopsys in a research note on Thursday, August 22nd. Rosenblatt Securities reissued a “buy” rating and set a $635.00 price objective on shares of Synopsys in a report on Friday, August 23rd. Piper Sandler restated an “overweight” rating and issued a $687.00 target price on shares of Synopsys in a research report on Thursday, August 22nd. JPMorgan Chase & Co. increased their price target on shares of Synopsys from $655.00 to $685.00 and gave the company an “overweight” rating in a research report on Thursday, August 22nd. Finally, Robert W. Baird boosted their price objective on shares of Synopsys from $661.00 to $663.00 and gave the stock an “outperform” rating in a report on Thursday, August 22nd. Eleven investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $630.09.

View Our Latest Stock Report on Synopsys

Insider Buying and Selling

In other news, insider Geus Aart De sold 8,158 shares of the firm’s stock in a transaction dated Thursday, June 27th. The shares were sold at an average price of $602.59, for a total value of $4,915,929.22. Following the completion of the sale, the insider now directly owns 106,983 shares of the company’s stock, valued at approximately $64,466,885.97. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In related news, CEO Sassine Ghazi sold 10,293 shares of the company’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $553.89, for a total value of $5,701,189.77. Following the sale, the chief executive officer now directly owns 62,568 shares of the company’s stock, valued at $34,655,789.52. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Geus Aart De sold 8,158 shares of the stock in a transaction on Thursday, June 27th. The stock was sold at an average price of $602.59, for a total value of $4,915,929.22. Following the completion of the transaction, the insider now owns 106,983 shares of the company’s stock, valued at approximately $64,466,885.97. The disclosure for this sale can be found here. Insiders sold 73,687 shares of company stock valued at $44,616,637 over the last quarter. 0.66% of the stock is owned by company insiders.

About Synopsys

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

See Also

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.